Christoph Schwering

4PUBLICATIONS
4CO-AUTHORS
Neurology and neuromuscular diseasesInfant and child healthGene and molecular therapyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 23, 2026
Mapping Clinical Progression to Brain Atrophy in CLN2 Patients Under Cerliponase Alfa Treatment: A Prospective Neuroimaging Study.

|Jul 17, 2022
Therapeutic Management of COVID-19 in a Pediatric Patient with Neurodegenerative CLN2 Disease and ICV-Enzyme Replacement Therapy: A Case Report.

Christoph Schwering, Sofia Apostolidou, Philipp Deindl

|Feb 05, 2021
Development of the "Hamburg Best Practice Guidelines for ICV-Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients.

Christoph Schwering, Gertrud Kammler, Eva Wibbeler

|Dec 28, 2020
Cerliponase Alfa for the Treatment of Atypical Phenotypes of CLN2 Disease: A Retrospective Case Series.

Eva Wibbeler, Raymond Wang, Emily de Los Reyes

Pageof 1

Frequent Collaborators

2 joint publications

Angela Schulz

1 joint publications

Renée Shediac

1 joint publications

Marvin Petersen

1 joint publications

Felix L Naegele